SK hynix's $28 Billion Nasdaq IPO and the 2026 Equity Supply Test

SK hynix launched its US initial public offering on Monday, July 6, 2026, setting terms for what would be the second-largest IPO on record. The South Korean memory semiconductor giant plans to raise $28.1 billion by offering 177.9 million American Depositary Shares at $158.14 — the as-converted July 3 close of its existing shares on the Korea Exchange’s KOSPI market.{{cite:189c3eadc069}} At that price, SK hynix would command a market capitalization of approximately $1.2 trillion.{{cite:189c3eadc069}} Cornerstone investors Baillie Gifford, Coatue Management, and Situational Awareness Partners have indicated interest in $7 billion of the deal, representing 24.9% of the offering.{{cite:189c3eadc069}} The ADSs are expected to list on the Nasdaq under the symbol SKHY, with pricing targeted for the week of July 6.{{cite:189c3eadc069}}

The company is not a startup discovering public markets for the first time. Founded in 1983 and already KOSPI-listed under ticker 000660, SK hynix booked $84.9 billion in revenue for the trailing twelve months ended March 31, 2026, and ranked first or second globally in DRAM, high-bandwidth memory (HBM), and NAND flash by revenue in the first quarter.{{cite:189c3eadc069}} Proceeds from the ADR offering will fund chip factory construction in South Korea and equipment purchases, capitalizing on AI-driven demand for memory.{{cite:fff55f51ce18}} The underwriting syndicate is among the largest assembled for any IPO — BofA Securities, Citi, Goldman Sachs, J.P. Morgan, Cantor Fitzgerald, Mizuho, Needham, RBC Capital Markets, Rosenblatt, Stifel, Wedbush, William Blair, and Nomura are all on the ticket.{{cite:189c3eadc069}}

The 2026 issuance pipeline

SK hynix lands on top of an already historic issuance calendar. Renaissance Capital data shows 79 US IPOs have raised $112.5 billion year-to-date through early July 2026, a 625% increase year over year.{{cite:265304e91aff}} UBS projects full-year IPO issuance of $200–350 billion, with secondary offerings adding to the total.{{cite:265304e91aff}} ArcStone Financial Pulse reports US equity issuance topped $120 billion in the first half — the strongest H1 pace since 2021 — driven by AI-infrastructure IPOs, sponsor-driven follow-ons, and a record run of convertible issuance.{{cite:5dde89c6caf4}}

The marquee deal that cracked the window open was SpaceX, which priced at an $86 billion valuation in late June{{cite:5dde89c6caf4}} in what was reported as a $75 billion capital raise.{{cite:265304e91aff}} Nasdaq’s year-to-date IPO run has reached $129 billion.{{cite:5dde89c6caf4}} After SK hynix prices, the visible pipeline includes Csquare (CSQR), targeting $1.25 billion, and MetaOptics (MOT), a small $18 million deal.{{cite:d1afde323abc}}

The pattern is clear: the 2026 IPO market is no longer reopening — it is open, and the deals are getting bigger. General Atlantic’s capital markets head observed that the next phase may be defined less by mega-deals themselves than by what follows: a broader opening incorporating mid-cap issuers, underrepresented sectors, and markets beyond this year’s busiest geographies.{{cite:5dde89c6caf4}}

The supply-absorption question

The core structural question is whether investor demand can absorb this volume of new equity without forcing sales of existing holdings. The concern is mechanical: to buy $28 billion of SK hynix ADSs, investors need cash, and raising it often means selling something else. TheStreet reported that SpaceX, Anthropic, and OpenAI are collectively part of a $200 billion IPO wave that could trigger a trillion-dollar sell-off in existing stocks as investors rotate capital.{{cite:265304e91aff}}

The June stress test offered reassurance. Two high-profile deals totaling $140 billion in notional value — the first and second largest primary capital raises in US market history within a two-week period — were absorbed by institutional and retail demand without disrupting broader markets.{{cite:42ebfba21f11}} Gavekal Research estimated that SpaceX’s $75 billion raise would absorb just over two weeks of shareholder payouts (dividends and buybacks), providing a sense of scale for what the market routinely processes.{{cite:265304e91aff}}

But the margin is not unlimited. J.P. Morgan noted that the IPO wave is historic but so is today’s market — implicitly framing the supply test as a race between issuance volume and the depth of demand.{{cite:265304e91aff}} Personal consumption growth fell to 0.5% in the first quarter of 2026 from 3.5% in the third quarter of 2025, a signal that the real economy may be cooling even as the capital markets run hot.{{cite:42ebfba21f11}} The SPDR S&P 500 ETF (SPY) was down 2.17% over the trailing month as of late June.{{cite:42ebfba21f11}}

The buyback counterweight

The quiet structural bid against new issuance is corporate America’s own repurchase machine. US corporations are on pace for approximately $1.2 trillion in share repurchases in 2026, according to multiple estimates.{{cite:d6a73e1cc32e}} What is new is not the dollar total — buybacks have been large for years — but the breadth. The number of active daily repurchase programs on corporate buyback desks has surged from roughly 10 two years ago to between 50 and 60 this year, with mid-cap and industrial companies joining the Magnificent Seven names that traditionally dominated the flow.{{cite:42ebfba21f11}}

The profit pool funding this bid is large and broadening. Total corporate profits hit $4.4 trillion in the first quarter of 2026, up 12.8% year over year, with domestic profits at $3.86 trillion.{{cite:42ebfba21f11}} Manufacturing profits jumped to $773.3 billion from $591.1 billion a year earlier, and information technology profits rose to $352.5 billion from $271.0 billion.{{cite:42ebfba21f11}} That manufacturing breakout is significant: it sits outside the Mag Seven and signals that CFOs in sectors not associated with AI hype now have the balance sheets and board authorization to retire shares.

The Invesco BuyBack Achievers ETF (PKW) is up 17% over the past year, closing the gap with SPY’s 20% gain — suggesting the buyback cohort is tracking the index rather than lagging it.{{cite:42ebfba21f11}} If 50 to 60 corporate repurchase programs are running daily, every dollar of new IPO paper has a structural buyer waiting at the close. That is the mechanism that absorbed the $140 billion June supply shock without dislocation.{{cite:42ebfba21f11}}

The tension ahead

Put the two sides together and the picture is a race. On one side: $200–350 billion in projected IPO issuance, anchored by SK hynix’s $28.1 billion this week, with SpaceX, potential OpenAI and Anthropic offerings, and a broadening pipeline behind it. On the other: $1.2 trillion in buybacks, 50–60 daily repurchase programs, and corporate profits growing at nearly 13%. The buyback bid is roughly four to six times the projected IPO supply — which is why the market has absorbed everything thrown at it so far.

The vulnerability is not in the arithmetic of supply versus demand. It is in the composition. Buybacks are funded by profits, and profits are funded by revenue, and revenue growth is decelerating. If personal consumption continues to soften and earnings momentum fades in the second half, the corporate bid narrows at exactly the moment the IPO calendar is accelerating. The June stress test passed because both sides of the equation were at full strength. The next test — SK hynix this week, and whatever follows in September after the summer lull — will show whether the balance holds when the demand side begins to cool.

What to watch next

• SK hynix pricing and first-day performance (week of July 7): The deal is 25% pre-sold to cornerstone investors, which reduces pricing risk but also reduces the float available for genuine price discovery.{{cite:189c3eadc069}} Watch the remaining 75% — that is where supply absorption gets tested.
• Post-IPO lockup mechanics: As a secondary listing of an already-public company, SK hynix’s ADRs do not carry a traditional 180-day lockup in the same way a fresh IPO would. The KRX-listed shares are freely tradeable, meaning arbitrage between the two listings could cap upside — or amplify selling pressure if the ADR premiums over KRX.
• Q2 2026 earnings season (mid-July): JPMorgan’s $50 billion buyback authorization provides a yardstick for whether bank capital returns are accelerating or moderating.{{cite:696300f61196}} More broadly, the Q2 reporting cycle will reveal whether corporate profit growth — the engine funding the $1.2 trillion buyback bid — is maintaining its 12.8% pace or decelerating.
• September IPO pipeline: The summer lull typically runs from mid-July through Labor Day. The post-Labor-Day window is when the next wave of deals traditionally launches. If the SK hynix pricing goes smoothly, expect a crowded September calendar.
• Consumer spending data: Q1 2026 personal consumption growth fell to 0.5% from 3.5% two quarters earlier.{{cite:42ebfba21f11}} If Q2 data confirms this deceleration, the revenue-side support for corporate profits — and by extension the buyback bid — weakens at a time when issuance supply is rising.